Authors: Shuyana Deba Rementeria, Javier Del Río Riego and Sara Sanz Juste
Since 2015, the fertility-related company OvaScience from Canada has recently launched a new technique called AUGMENT, which has resulted in high controversy around the world.
WHAT IS AUGMENT?
It is a new IVF technique designed to improve women’s oocyte quality.
How does it work? Through this technique, doctors have to biopsy tissue from the lining ovaries of a woman normally under general anaesthesia, the entire procedure being performed via laparoscopic surgery. Then, samples are transported to the OvaScience laboratory, where the mitochondria from egg precursor cells are isolated and subsequently transferred through ICSI into a mature egg, as well as the sperm.
Serving patients in a total of six countries: Canada, Spain, Japan, Panama, Turkey and United Arab Emirates.
What do you think about it? Do you think it is a useful technique? Would you offer this approach at your fertility clinic?
You can read more about OvaScience and their treatments in the following links. If you cannot find any paper, let us know and we will send it to you.
In the scientific area:
Fakih M. The AUGMENTSM Treatment: Physician Reported Outcomes of the Initial Global Patient Experience. Journal of Fertilization: In Vitro - IVF-Worldwide, Reproductive Medicine, Genetics & Stem Cell Biology. 2015;03(03).
Couzin-Frankel J. Eggs unlimited. Science. 2015;350(6261):620-624.
Imudia A, Wang N, Tanaka Y, White Y, Woods D, Tilly J. Comparative gene expression profiling of adult mouse ovary-derived oogonial stem cells supports a distinct cellular identity. Fertility and Sterility. 2013;100(5):1451-1458.e2.
Woods D, Tilly J. Isolation, characterization and propagation of mitotically active germ cells from adult mouse and human ovaries. Nature Protocols. 2013;8(5):966-988.
In the media:
Join our mailing list and keep yourself up to date!
2016-2018. All Rights Reserved by Embryologist Media.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.